Comparison of Postoperative Anti-nausea and Vomiting Effect Between Glycopyrronium and Ondansetron
NCT05265507 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 480
Last updated 2023-02-24
Summary
To compare the anti-nausea and vomiting effect between glycopyrronium and ondansetron for patients receiving elective surgery under general anesthesia. Based on this study the investigators intend to explore the feasibility of using glycopyrronium to prevent postoperative nausea and vomiting.
Conditions
- Postoperative Nausea and Vomiting
Interventions
- DRUG
-
Glycopyrronium
Glycopyrronium (0.2mg) was intravenously given at the ending of the surgery.
- DRUG
-
Ondansetron
Glycopyrronium (4mg) was intravenously given at the ending of the surgery.
Sponsors & Collaborators
-
Chongqing University Jiangjin Hospital
collaborator UNKNOWN -
Chongqing Medical University
collaborator OTHER -
The People's Hospital of DAZU ，Chongqing
collaborator UNKNOWN -
Xiangya Hospital of Central South University
collaborator OTHER -
West China Hospital
collaborator OTHER -
The People's Hospital of Tongliang District， Chongqing city
collaborator UNKNOWN -
Chongqing Medical Center for Women and Children
collaborator OTHER -
Dianjiang People's Hospital of Chongqing
collaborator UNKNOWN -
The Ninth People's Hospital of Chongqing
collaborator UNKNOWN -
The People's Hospital of Yubei District of Chongqing city
collaborator UNKNOWN -
Chongqing Yongchuan District People's Hospital
collaborator UNKNOWN -
The First People's Hospital Of Chongqing Liang Jiang New Area
collaborator UNKNOWN -
ChongGang General Hospital
collaborator UNKNOWN -
The People's Hospital of Nanchuan
collaborator UNKNOWN -
People's Hospital of Pengshui County
collaborator UNKNOWN -
Yunyang people's Hospital
collaborator UNKNOWN -
Chongqing Liangping District People's Hospital
collaborator UNKNOWN -
Jiulongpo People's Hospital of chongqing
collaborator UNKNOWN -
The People's Hospital of Qijiang District，Chongqing
collaborator UNKNOWN -
University-Town Hospital of Chongqing Medical University
collaborator OTHER -
Chongqing Public Health Medical Center
collaborator OTHER -
CHONGQING BANAN HOSPITAL OF TCM
collaborator UNKNOWN -
The Second Affiliated Hospital of Chongqing Medical University
lead OTHER
Principal Investigators
-
He Huang, MD · The Second Affiliated Hospital, Chongqing Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-21
- Primary Completion
- 2023-05-30
- Completion
- 2023-05-30
Countries
- China
Study Locations
More Related Trials
-
A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting
NCT00108095 ·Status: COMPLETED ·Phase: PHASE2
-
Ondansetron Combined with Dyclonine Hydrochloride to Improve Patient Experience in Unsedated Esophagogastro-duodenoscopy
NCT06729307 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Ondansetron vs. Dexamethasone for Postoperative Nausea
NCT06886230 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation
NCT06045364 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk for Nausea and Vomiting Undergoing Gynecological Surgery
NCT06887621 ·Status: RECRUITING ·Phase: PHASE2
-
the Efficacy and Safety of Ondansetron Oral Soluble Pellicles
NCT06282211 ·Status: RECRUITING ·Phase: PHASE3
-
Dexamethasone vs Ondansetron After Cesarean Delivery
NCT05692245 ·Status: COMPLETED ·Phase: PHASE4
-
An Economic Study of HSK21542 Injection for Prevention of Postoperative Nausea and Vomiting
NCT06359535 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension
NCT01669213 ·Status: UNKNOWN ·Phase: NA
-
Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women
NCT00326248 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015)
NCT00231777 ·Status: COMPLETED ·Phase: PHASE3
-
Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting
NCT01474915 ·Status: COMPLETED ·Phase: PHASE4
-
Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department
NCT00590317 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting
NCT06932107 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Controlled Study of Rolapitant for the Prevention of Nausea and Vomiting Following Surgery (Study P04937AM1)(COMPLETED)
NCT00539721 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults
NCT06475846 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study on the Efficacy and Safety of Ondansetron Oral Membrane for the Prevention of Vomiting During Moderate Hypoemetic Chemotherapy
NCT06371014 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer
NCT06697782 ·Status: COMPLETED ·Phase: PHASE4
-
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
NCT00334152 ·Status: COMPLETED ·Phase: PHASE3
-
Ondansetron VS Doxylamine and Pyridoxine in Treating Nausea of Pregnancy
NCT01668069 ·Status: COMPLETED ·Phase: NA
-
Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis
NCT01165866 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia
NCT03865290 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Nicotine for the Prevention of PONV
NCT00553709 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients
NCT01395901 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of B6 and Metoclopramide Combination in Comparison With the Other Antiemetics
NCT06390787 ·Status: COMPLETED ·Phase: PHASE2/PHASE3